Stuart J Birtwistle

Learn More
The management of periprosthetic femoral fractures is difficult and challenging. Nonsurgical and surgical treatment modalities have been described. We reviewed 24 patients (average age, 74 years) with types B2 and B3 fractures (Vancouver classification) managed with a cementless, tapered, fluted, and distally fixed stem using a transfemoral approach. Most(More)
We report the results of the Charnley Elite Plus femoral stem in multiple surgeons’ hands at a minimum of 3 years after implantation. Over a 4-year period, 244 patients underwent 268 primary hip arthroplasty procedures using this particular stem. Patients underwent postal and radiographic review at a mean of 4.5 (3.0–6.8) years following their arthroplasty.(More)
We randomised 120 patients who were undergoing either primary total hip or knee arthroplasty to receive either ferrous sulphate or a placebo for three weeks after surgery. The level of haemoglobin and absolute reticulocyte count were measured at one and five days, and three and six weeks after operation. Ninety-nine patients (ferrous sulphate 50, placebo(More)
The results of 1555 primary total hip replacements in 1375 patients performed over an 11-year period were reviewed. When analysed by standard life tables, our findings show encouraging results with survival rates of 96% at 10 years, and are similar to those already published from specialist units. In all, 35 patients had undergone revision surgery. The most(More)
Revision hip arthroplasty is an operation which is steadily increasing in number and can often be technically challenging. We have utilised a regional hip register (the Trent Regional Arthroplasty Study) to analyse the epidemiology of revision hip arthroplasties in a single UK health region. The study shows that of the large number (1265) of procedures(More)
The incidence of MRSA or MRSE type infections involving hip prostheses is increasing. Treatment often involves removal of the prosthesis followed by a defined period of antibiotic treatment, prior to insertion of a second prosthesis. Vancomycin is often used in this setting. We report a fatal case of toxic epidermal necrolysis (TEN) in a patient receiving(More)